.jpg)
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
Emalex Biosciences’ dopamine blocker led to fewer patients with Tourette syndrom...
In addition to the previously disclosed two deaths, the FDA said in its February...
TUESDAY, Feb. 25, 2025 -- The association of long-term yogurt intake with color...
TUESDAY, Feb. 25, 2025 -- Menthol cigarettes are associated with increased mort...
TUESDAY, Feb. 25, 2025 -- Diabetes mellitus type 1 (DM1) is associated with low...
TUESDAY, Feb. 25, 2025 -- There is a dose-response relationship between physica...
TUESDAY, Feb. 25, 2025 -- Vitamin D deficiency (VDD) is independently associate...
TUESDAY, Feb. 25, 2025 -- The risk for myopia increases significantly with one ...
TUESDAY, Feb. 25, 2025 -- Administration of ketamine for purposes other than ac...
TUESDAY, Feb. 25, 2025 -- For night shift workers, melatonin supplementation se...
Telehealth provider Hims & Hers said it will tell consumers they need to seek “a...
In the latest edition of STAT Health Tech newsletter: Telehealth risks becoming ...
The company is adding higher-dose Zepbound options to its online pharmacy and tr...
Compounding pharmacies aren’t surrendering their ability to create cheaper knock...
Blood test maker Grail has recruited ‘Grey’s Anatomy’ star Kate Walsh to join a ...
On the heels of a move to reduce its viral vector manufacturing workforce, Therm...
Human medicines European public assessment report (EPAR): Xtandi, enzalutamide, ...
As Stelara biosimilars gradually make their way on to the U.S. market, Johnson &...
Lilly expands its Zepbound vial offering, as HIMS pulls back on semaglutide, and...
This week in health care politics and policy: FDA rehires staff, former drug reg...
Medicinal products for human use: monthly figures - January 2025
CTIS newsflash - 25 February 2025
Kiniksa Pharmaceuticals is stopping development of a midphase autoimmune asset a...
Ryvu Therapeutics is shrinking its headcount by 30% as the Polish biotech focuse...